Use of reliever therapies, e.g. beta₂‐agonists (reliever therapies) · children with asthma
It is very uncertain whether effects of school‐based asthma interventions changes use of reliever therapies, e.g. beta₂‐agonists (reliever therapies) compared with usual care (very low certainty).
1 finding from 1 review
Health‐related quality of life · children with asthma
1 finding from 1 review
Respiratory exacerbations: number of respiratory exacerbations per year · Adults with COPD
1 finding from 1 review
Exacerbations needing hospitalisation · Adults with COPD
1 finding from 1 review
All‐cause mortality · Adults with COPD
Statins showed no clear difference in all‐cause mortality compared with placebo (low certainty).
1 finding from 1 review
COPD‐specific mortality · Adults with COPD
Statins showed no clear difference in COPD‐specific mortality compared with placebo (low certainty).
1 finding from 1 review
Quality of life · Adults with COPD
Statins led to lower quality of life compared with placebo; GRADE not reported.
1 finding from 1 review
Adverse events · Adults with COPD
1 finding from 1 review
Improvement in WHO functional class · pulmonary arterial hypertension
Group 1 Pulmonary arterial hypertension ‐ PDE5i leads to higher improvement in WHO functional class compared with placebo (high certainty).
1 finding from 1 review
Six‐minute walk distance · pulmonary arterial hypertension
1 finding from 1 review
All‐cause mortality · pulmonary arterial hypertension
Group 1 Pulmonary arterial hypertension ‐ PDE5i showed no clear difference in mortality compared with placebo, on combination therapy (moderate certainty).
1 finding from 1 review
Physical functioning component of health‐related quality of life, measured using various scales · pulmonary arterial hypertension
1 finding from 1 review
PAP · pulmonary arterial hypertension
1 finding from 1 review
Cardiac output · pulmonary arterial hypertension
1 finding from 1 review
PVR · pulmonary arterial hypertension
1 finding from 1 review
Improvement in WHO functional class · pulmonary arterial hypertension
Group 1 Pulmonary arterial hypertension ‐ PDE5i showed no clear difference in improvement in WHO functional class compared with ERA (moderate certainty).
1 finding from 1 review
Six‐minute walk distance · pulmonary arterial hypertension
1 finding from 1 review
All‐cause mortality · pulmonary arterial hypertension
Group 1 Pulmonary arterial hypertension ‐ PDE5i showed no clear difference in mortality compared with ERA (moderate certainty).
1 finding from 1 review
Quality of life Kansas City Cardiomyopathy Quality‐of‐Life questionnaire (higher scores indicate better quality of life) · pulmonary arterial hypertension
1 finding from 1 review
Six‐minute walk distance · pulmonary arterial hypertension
1 finding from 1 review